Regulations.gov document
Completeness Assessment Correspondence from FDA CDER to Hospira Inc.
Other · FDA-2023-P-4334 · posted Oct 23, 2023
Key facts
| Document ID | FDA-2023-P-4334-0006 |
|---|---|
| Title | Completeness Assessment Correspondence from FDA CDER to Hospira Inc. |
| Document type | Other |
| Subtype | Correspondence |
| Agency | FDA |
| Docket | FDA-2023-P-4334 |
| Posted | Oct 23, 2023 |
| Comment period opens | Oct 23, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: